Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.240
+0.020 (1.64%)
At close: Dec 31, 2025, 4:00 PM EST
1.210
-0.030 (-2.41%)
After-hours: Dec 31, 2025, 7:43 PM EST
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $87.67 million as of December 31, 2025. Its market cap has decreased by -57.10% in one year.
Market Cap
87.67M
Enterprise Value
47.91M
1-Year Change
-57.10%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $87.67M, a decrease of -82.07%. That is a compound annual growth rate of -30.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | 489.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |